Tests:CA 125: Difference between revisions
Tests:CA 125
corrected sample types etc |
No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 34: | Line 34: | ||
|Specimen | |Specimen | ||
|Serum | |Serum | ||
|- | |- | ||
|Preferred | |Preferred | ||
| Line 73: | Line 72: | ||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Alinity | |Abbott Alinity i series analyser using Abbott reagents. Chemiluminescent microparticle immunoassay. | ||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| Line 90: | Line 87: | ||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||
<!-- review-ping: 2026-09-14T07:57:57.920Z --> | |||